Or call 888-224-2480 for fastest service.

You can save an extra 10% off the current rate by using code D10-999-JDS22.

Premier forum which shapes the law, policy, and proceedings of Paragraph IV Litigation is back to New York City on April 26-27!

Pharmaceutical patent practitioners from across the globe attend this flagship conference to confer with each other and assess the implications and imprimaturs of court cases, legislation, and industry behaviors which affect the patent endgame and the pursuit of related profits. They also come to hear from Judges — both from the federal judiciary, and U.S. P.T.O.’s PTAB —, the FTC, and the FDA.

2022 CO-CHAIRS

This single forum serves both sides of the industry and is second to none in offering both legal and economic “take aways” for every sphere of this costly, complex, and evolving litigation. It is the only event on market which not only addresses the hot topics, but also puts them within the context of pre-suit considerations, case filings, final adjudication, and every step in between. This unique dynamic exemplifies not only the importance of the content and legal theory presented, but the contending business acuities as well.

2022 AGENDA HIGHLIGHTS INCLUDE

• The Viability of Written Description as a Compelling Invalidity Defense
• Clarity On What Satisfies Section 1400(b)’s Venue Requirements in the Hatch-Waxman Context
• Whether a Skinny Label Alone Is Enough to Preclude Induced Infringement Allegations
• The Latest FDA Initiatives Impacting Pharmaceutical Patents -Restrictions on Reverse-Payment Settlements

Join the conference that the “who’s who” of Hatch-Waxman litigators have designated as the forum which sets the standards for Paragraph IV practice.

Save an extra 10% off the conference by using code D10-999-JDS22.

*Discount is valid for new registrations only and it’s not applicable for workshops.